<!DOCTYPE html>
<html lang="tr">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>GLP-1 mi, ESG mi? 9 Boyutta KapsamlÄ± KarÅŸÄ±laÅŸtÄ±rma | UzunYaÅŸa</title>
    <meta name="description" content="Ä°laÃ§ tedavisi mi, endoskopik prosedÃ¼r mÃ¼? Etkinlik, kalÄ±cÄ±lÄ±k, maliyet ve daha fazlasÄ± â€” doÄŸru karar iÃ§in 9 kritik boyut.">
    <link href="https://fonts.googleapis.com/css2?family=Inter:wght@400;500;600;700;800&family=Playfair+Display:wght@500;600&display=swap" rel="stylesheet">
    <style>
        :root { --primary: #195157; --accent: #E8963E; --text: #1f2937; --text-gray: #6b7280; --bg: #FAF9F7; }
        * { margin: 0; padding: 0; box-sizing: border-box; }
        body { font-family: 'Inter', sans-serif; color: var(--text); line-height: 1.8; background: var(--bg); }
        .header { position: fixed; top: 0; left: 0; right: 0; z-index: 1000; background: rgba(255,255,255,0.97); backdrop-filter: blur(10px); border-bottom: 1px solid #e5e7eb; }
        .header-inner { max-width: 1200px; margin: 0 auto; padding: 0.75rem 2rem; display: flex; align-items: center; justify-content: space-between; }
        .logo-img { height: 50px; }
        .back-link { color: var(--primary); text-decoration: none; font-weight: 500; }
        article { max-width: 800px; margin: 0 auto; padding: 7rem 2rem 4rem; }
        .post-meta-top { display: flex; gap: 1rem; flex-wrap: wrap; margin-bottom: 1.5rem; }
        .post-category { display: inline-block; background: #6366f1; color: white; padding: 0.4rem 1rem; border-radius: 20px; font-size: 0.8rem; font-weight: 600; }
        .reading-time { color: var(--text-gray); font-size: 0.9rem; }
        h1 { font-family: 'Playfair Display', serif; font-size: 2.3rem; font-weight: 600; line-height: 1.2; margin-bottom: 1rem; }
        .subtitle { font-size: 1.15rem; color: var(--text-gray); margin-bottom: 2rem; }
        .featured-image { width: 100%; height: 280px; background: linear-gradient(135deg, #6366f1, #4f46e5); border-radius: 16px; margin-bottom: 2rem; display: flex; align-items: center; justify-content: center; }
        .featured-image span { font-size: 4rem; }
        .content p { margin-bottom: 1.5rem; font-size: 1.05rem; }
        .content h2 { font-size: 1.5rem; font-weight: 700; margin: 2.5rem 0 1rem; color: var(--primary); padding-top: 1rem; border-top: 1px solid #e5e7eb; }
        .content h3 { font-size: 1.2rem; font-weight: 600; margin: 1.5rem 0 0.75rem; }
        .content ul { margin: 1.5rem 0; padding-left: 1.5rem; }
        .content li { margin-bottom: 0.5rem; }
        .info-box { background: #eef2ff; border-left: 4px solid #6366f1; padding: 1.25rem; border-radius: 0 12px 12px 0; margin: 1.5rem 0; }
        .success-box { background: #f0fdf4; border-left: 4px solid #10b981; padding: 1.25rem; border-radius: 0 12px 12px 0; margin: 1.5rem 0; }
        .warning-box { background: #fef3c7; border-left: 4px solid #f59e0b; padding: 1.25rem; border-radius: 0 12px 12px 0; margin: 1.5rem 0; }
        table { width: 100%; border-collapse: collapse; margin: 1.5rem 0; font-size: 0.9rem; }
        th, td { padding: 0.75rem; text-align: left; border-bottom: 1px solid #e5e7eb; }
        th { background: #f8fafc; font-weight: 600; }
        .compare-card { background: white; border: 1px solid #e5e7eb; border-radius: 12px; padding: 1.25rem; margin: 1rem 0; }
        .compare-card h4 { color: var(--primary); margin-bottom: 0.5rem; font-size: 1.1rem; }
        .cta-box { background: linear-gradient(135deg, var(--primary), #2a7d83); color: white; padding: 2rem; border-radius: 16px; text-align: center; margin: 3rem 0; }
        .cta-btn { display: inline-block; background: white; color: var(--primary); padding: 0.75rem 1.5rem; border-radius: 8px; text-decoration: none; font-weight: 600; }
        footer { background: var(--text); color: white; padding: 2rem; text-align: center; }
        @media (max-width: 640px) { h1 { font-size: 1.75rem; } article { padding: 6rem 1rem 3rem; } }
    </style>
</head>
<body>
    <header class="header">
        <div class="header-inner">
            <a href="../../index.html"><img src="../../images/logo.svg" alt="UzunYaÅŸa" class="logo-img"></a>
            <a href="../blog.html" class="back-link">â† Blog</a>
        </div>
    </header>

    <article>
        <div class="post-meta-top">
            <span class="post-category">âš–ï¸ KarÅŸÄ±laÅŸtÄ±rma</span>
            <span class="reading-time">â±ï¸ 14 dk okuma â€¢ Åubat 2026</span>
        </div>
        
        <h1>GLP-1 mi, ESG mi? 9 Boyutta KapsamlÄ± KarÅŸÄ±laÅŸtÄ±rma</h1>
        <p class="subtitle">Ä°laÃ§ tedavisi mi, endoskopik prosedÃ¼r mÃ¼? Etkinlik, kalÄ±cÄ±lÄ±k, maliyet ve daha fazlasÄ± â€” doÄŸru karar iÃ§in bilmeniz gereken her ÅŸey.</p>

        <div class="featured-image"><span>âš–ï¸</span></div>

        <div class="content">
            <h2>HÄ±zlÄ± KarÅŸÄ±laÅŸtÄ±rma Tablosu</h2>
            <table>
                <tr><th>Boyut</th><th>GLP-1 Ä°laÃ§larÄ±</th><th>ESG</th></tr>
                <tr><td><strong>1. Etkinlik</strong></td><td>%15-22 kilo kaybÄ±</td><td>%15-20 kilo kaybÄ±</td></tr>
                <tr><td><strong>2. KalÄ±cÄ±lÄ±k</strong></td><td>DÃ¼ÅŸÃ¼k (bÄ±rakÄ±nca geri alÄ±m)</td><td>YÃ¼ksek (yapÄ±sal deÄŸiÅŸiklik)</td></tr>
                <tr><td><strong>3. Ä°nvazivlik</strong></td><td>Yok (enjeksiyon)</td><td>Minimal (endoskopik)</td></tr>
                <tr><td><strong>4. Ä°yileÅŸme</strong></td><td>Yok</td><td>3-7 gÃ¼n</td></tr>
                <tr><td><strong>5. Maliyet</strong></td><td>YÃ¼ksek (aylÄ±k devam)</td><td>Orta-yÃ¼ksek (tek seferlik)</td></tr>
                <tr><td><strong>6. Yan Etkiler</strong></td><td>GI semptomlar, kas kaybÄ±</td><td>Hafif, kÄ±sa sÃ¼reli</td></tr>
                <tr><td><strong>7. Ek Faydalar</strong></td><td>KardiyovaskÃ¼ler, bÃ¶brek</td><td>SÄ±nÄ±rlÄ±</td></tr>
                <tr><td><strong>8. Geri DÃ¶nÃ¼ÅŸÃ¼m</strong></td><td>Tam</td><td>KÄ±smen</td></tr>
                <tr><td><strong>9. Uygunluk</strong></td><td>BMI 27+</td><td>BMI 30-40</td></tr>
            </table>

            <h2>1. Etkinlik: Ne Kadar Kilo Verilir?</h2>
            <div class="compare-card">
                <h4>ğŸ’Š GLP-1 Ä°laÃ§larÄ±</h4>
                <ul>
                    <li>Semaglutid 2.4 mg: <strong>%14.9-15.2</strong> (68-104 hafta)</li>
                    <li>Tirzepatid 15 mg: <strong>%22.5</strong> (72 hafta)</li>
                </ul>
            </div>
            <div class="compare-card">
                <h4>ğŸ”¬ ESG</h4>
                <ul>
                    <li>12 ayda: <strong>%15-17</strong> TBWL</li>
                    <li>5 yÄ±lda: <strong>%15.9</strong> korunuyor</li>
                </ul>
            </div>
            <p><strong>SonuÃ§:</strong> Tirzepatid en yÃ¼ksek, ESG ve semaglutid benzer etkinlikte.</p>

            <h2>2. KalÄ±cÄ±lÄ±k: BÄ±rakÄ±nca Ne Olur?</h2>
            <div class="warning-box">
                <strong>âš ï¸ GLP-1 Ä°laÃ§larÄ±:</strong> BÄ±rakÄ±ldÄ±ÄŸÄ±nda 1 yÄ±l iÃ§inde kaybedilen kilonun <strong>%67'si</strong> geri alÄ±nÄ±yor.
            </div>
            <div class="success-box">
                <strong>âœ… ESG:</strong> 5 yÄ±lda ortalama geri alÄ±m sadece <strong>2.9 kg</strong>. YapÄ±sal deÄŸiÅŸiklik kalÄ±cÄ±.
            </div>

            <h2>3. Ä°nvazivlik ve Ä°yileÅŸme</h2>
            <table>
                <tr><th>Ã–zellik</th><th>GLP-1</th><th>ESG</th></tr>
                <tr><td>ProsedÃ¼r</td><td>HaftalÄ±k enjeksiyon</td><td>Tek seferlik endoskopi</td></tr>
                <tr><td>Anestezi</td><td>Yok</td><td>Genel/sedasyon</td></tr>
                <tr><td>Hastane yatÄ±ÅŸÄ±</td><td>Yok</td><td>0-1 gece</td></tr>
                <tr><td>Ä°ÅŸe dÃ¶nÃ¼ÅŸ</td><td>AynÄ± gÃ¼n</td><td>3-7 gÃ¼n</td></tr>
            </table>

            <h2>4. Yan Etkiler</h2>
            <h3>GLP-1 Ä°laÃ§larÄ±</h3>
            <ul>
                <li><strong>BulantÄ±:</strong> %30-45</li>
                <li><strong>Kusma:</strong> %15-25</li>
                <li><strong>Kas kaybÄ±:</strong> Kaybedilen kilonun %39-45'i</li>
                <li>Ã‡oÄŸu ilk haftalarda azalÄ±r</li>
            </ul>

            <h3>ESG</h3>
            <ul>
                <li><strong>BulantÄ±/kusma:</strong> Ä°lk 1-3 gÃ¼n, sonra geÃ§er</li>
                <li><strong>Ciddi komplikasyon:</strong> ~%1.5</li>
                <li><strong>Kas kaybÄ±:</strong> Minimal</li>
            </ul>

            <h2>5. Ek SaÄŸlÄ±k FaydalarÄ±</h2>
            <div class="info-box">
                <strong>ğŸ’Š GLP-1 AvantajÄ±:</strong>
                <ul>
                    <li>KardiyovaskÃ¼ler olaylarÄ± <strong>%20</strong> azaltÄ±r (SELECT)</li>
                    <li>BÃ¶brek hastalÄ±ÄŸÄ±nÄ± <strong>%24</strong> yavaÅŸlatÄ±r (FLOW)</li>
                    <li>KaraciÄŸer yaÄŸlanmasÄ±nda <strong>%37</strong> dÃ¼zelme</li>
                </ul>
            </div>
            <p>ESG bu ek faydalarÄ± sunmaz â€” sadece kilo kaybÄ± saÄŸlar.</p>

            <h2>6. Maliyet (5 YÄ±llÄ±k)</h2>
            <table>
                <tr><th></th><th>GLP-1 (Wegovy)</th><th>ESG</th></tr>
                <tr><td>5 yÄ±llÄ±k toplam</td><td><strong>~950.000 TL</strong></td><td><strong>~180.000 TL</strong></td></tr>
            </table>

            <h2>Karar Rehberi</h2>
            <h3>GLP-1 tercih edilebilir:</h3>
            <ul>
                <li>Herhangi bir prosedÃ¼r istemiyorsanÄ±z</li>
                <li>KardiyovaskÃ¼ler veya bÃ¶brek hastalÄ±ÄŸÄ±nÄ±z varsa</li>
                <li>BMI 27-30 arasÄ±ysa</li>
                <li>Maliyet engel deÄŸilse</li>
            </ul>

            <h3>ESG tercih edilebilir:</h3>
            <ul>
                <li>Uzun vadeli/Ã¶mÃ¼r boyu ilaÃ§ istemiyorsanÄ±z</li>
                <li>BMI 30-40 arasÄ±ysa</li>
                <li>Maliyet Ã¶nemliyse</li>
                <li>KalÄ±cÄ± Ã§Ã¶zÃ¼m arÄ±yorsanÄ±z</li>
            </ul>

            <h3>Kombinasyon?</h3>
            <p>BazÄ± hastalar iÃ§in <strong>ESG + dÃ¼ÅŸÃ¼k doz GLP-1</strong> optimal olabilir â€” yapÄ±sal kÄ±sÄ±tlama + metabolik destek.</p>

            <div class="cta-box">
                <h3>Size uygun tedaviyi keÅŸfedin</h3>
                <p>KiÅŸiselleÅŸtirilmiÅŸ deÄŸerlendirme iÃ§in testimizi tamamlayÄ±n</p>
                <a href="../test.html" class="cta-btn">Teste BaÅŸla â†’</a>
            </div>
        </div>
    </article>

    <footer><p>Â© 2026 UzunYaÅŸa. TÄ±pta Yapay Zeka DerneÄŸi giriÅŸimidir.</p></footer>
</body>
</html>
